Tom 19 (2024): Continuous Publishing
Artykuł przeglądowy
Opublikowany online: 2024-07-18
Wyświetlenia strony
594
Wyświetlenia/pobrania artykułu
405
Dieta eliminacyjna w chorobie Leśniowskiego-Crohna — nowa metoda leczenia żywieniowego dzieci i dorosłych
DOI: 10.5603/pżk.100797
Postępy Żywienia Klinicznego 2024;19:64-73.
Streszczenie
Dieta eliminacyjna w chorobie Leśniowskiego-Crohna (CDED), w połączeniu z częściowym żywieniem dojelitowym (PEN), stanowi obiecujący model leczenia żywieniowego u pacjentów z Chorobą Leśniowskiego-Crohna. Poprzez eliminację produktów zapalnych oraz wprowadzenie żywienia dojelitowego, dieta ta wspomaga procesy regeneracji jelit. Najnowsze badania kliniczne sugerują, że CDED nie tylko indukuje, ale również utrzymuje remisję, oferując tym samym holistyczne podejście zarówno dla pacjentów pediatrycznych, jak i dorosłych. Aktualne wytyczne ESPEN zalecają uwzględnienie CDED jako formy leczenia, szczególnie u dzieci i młodych dorosłych z łagodną i umiarkowaną postacią choroby Leśniowskiego-Crohna. Ponadto, coraz więcej badań podkreśla znaczenie CDED w populacji dorosłych, podkreślając jej rolę jako istotnego elementu lub alternatywy dla leczenia farmakologicznego.
Słowa kluczowe: choroba Leśniowskiego-Crohnadieta eliminacyjna w chorobie Leśniowskiego-Crohnaleczenie żywienioweindukcja remisji
Referencje
- Dotson J, Boyle B. Crohn Disease. Pediatric Gastrointestinal and Liver Disease. 2021: 461–473.e8.
- Hebzda A, Szczeblowska D, Serwin D, et al. Choroba Leśniowskiego-Crohna - diagnostyka i leczenie. Pediatr i Med Rodz. 2011; 7(2): 98–103.
- Torres J, Mehandru S, Colombel JF, et al. Crohn's disease. The Lancet. 2017; 389(10080): 1741–1755.
- Mak WY, Zhao M, Ng SC, et al. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol. 2020; 35(3): 380–389.
- Holko P, Kawalec P, Stawowczyk E. Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012-2014: an analysis of nationwide databases. Eur J Gastroenterol Hepatol. 2018; 30(4): 456–464.
- Jakubowski A, Zagórowicz E, Kraszewska E, et al. Rising hospitalization rates for inflammatory bowel disease in Poland. Pol Arch Med Wewn. 2014; 124(4): 180–190.
- Zagórowicz E, Walkiewicz D, Kucha P, et al. Nationwide data on epidemiology of inflammatory bowel disease in Poland between 2009 and 2020. Pol Arch Intern Med. 2022; 132(5).
- Szymańska S, Matuszczyk M, Osuch M, et al. Inflammatory bowel disease - one entity with many molecular faces. Prz Gastroenterol. 2019; 14(4): 228–232.
- Chen GB, Lee SH, Brion MJA, et al. International IBD Genetics Consortium. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. Hum Mol Genet. 2014; 23(17): 4710–4720.
- Yanai H, Levine A, Hirsch A, et al. The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial. Lancet Gastroenterol Hepatol. 2022; 7(1): 49–59.
- Tracy M, Khalili H. You Are What You Eat? Growing Evidence That Diet Influences the Risk of Inflammatory Bowel Disease. J Crohns Colitis. 2022; 16(8): 1185–1186.
- Barros VJ, Severo JS, Mendes PH, et al. Effect of dietary interventions on inflammatory biomarkers of inflammatory bowel diseases: A systematic review of clinical trials. Nutrition. 2021; 91-92: 111457.
- Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021; 374: n1554.
- Lo CH, Khandpur N, Rossato SL, et al. Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study. Clin Gastroenterol Hepatol. 2022; 20(6): e1323–e1337.
- Szczubełek M, Pomorska K, Korólczyk-Kowalczyk M, et al. Effectiveness of Crohn's Disease Exclusion Diet for Induction of Remission in Crohn's Disease Adult Patients. Nutrients. 2021; 13(11).
- Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014; 15(3): 382–392.
- Gomollón F, Dignass A, Annese V, et al. ECCO. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis. 2017; 11(1): 3–25.
- LOUIS E, COLLARD A, OGER A, et al. Location and behavior of Crohn's disease according to Vienna classification evolution over the course of the disease. Gastroenterology. 2001; 120(5): A141–A141.
- Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55(6): 749–753.
- Grant A, Lerer T, Griffiths AM, et al. Assessing disease activity using the pediatric Crohn's disease activity index: Can we use subjective or objective parameters alone? World J Gastroenterol. 2021; 27(30): 5100–5111.
- Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020; 30(6): 492–506.
- Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018; 67(9): 1726–1738.
- Herrador-López M, Martín-Masot R, Navas-López VM. EEN Yesterday and Today … CDED Today and Tomorrow. Nutrients. 2020; 12(12).
- Sigall-Boneh R, Pfeffer-Gik T, Segal I, et al. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis. 2014; 20(8): 1353–1360.
- Nickerson KP, Chanin R, McDonald C. Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin. Gut Microbes. 2015; 6(1): 78–83.
- Fahoum L, Moscovici A, David S, et al. Digestive fate of dietary carrageenan: Evidence of interference with digestive proteolysis and disruption of gut epithelial function. Mol Nutr Food Res. 2017; 61(3).
- Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015; 519(7541): 92–96.
- Coutinho CM, Coutinho-Silva R, Zinkevich V, et al. Sulphate-reducing bacteria from ulcerative colitis patients induce apoptosis of gastrointestinal epithelial cells. Microb Pathog. 2017; 112: 126–134.
- Yusuf K, Saha S, Umar S. Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease. Biomedicines. 2022; 10(6).
- Antoniussen CS, Rasmussen HH, Holst M, et al. Reducing Disease Activity of Inflammatory Bowel Disease by Consumption of Plant-Based Foods and Nutrients. Front Nutr. 2021; 8: 733433.
- Levine A, Wine E, Assa A, et al. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019; 157(2): 440–450.e8.
- Sigall Boneh R, Van Limbergen J, Wine E, et al. Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn's Disease. Clin Gastroenterol Hepatol. 2021; 19(4): 752–759.
- Levine A, El-Matary W, Van Limbergen J. A Case-Based Approach to New Directions in Dietary Therapy of Crohn's Disease: Food for Thought. Nutrients. 2020; 12(3).
- Scarallo L, Banci E, Pierattini V, et al. Crohn's disease exclusion diet in children with Crohn's disease: a case series. Curr Med Res Opin. 2021; 37(7): 1115–1120.
- Niseteo T, Sila S, Trivić I, et al. Modified Crohn's disease exclusion diet is equally effective as exclusive enteral nutrition: Real-world data. Nutr Clin Pract. 2022; 37(2): 435–441.
- Matuszczyk M, Meglicka M, Wiernicka A, et al. Effect of the Crohn's Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn's Disease. J Clin Med. 2022; 11(14).
- Martín-Masot R, Herrador-López M, Navas-López VM. Dietary Habit Modifications in Paediatric Patients after One Year of Treatment with the Crohn's Disease Exclusion Diet. Nutrients. 2023; 15(3).
- Sigall Boneh R, Sarbagili Shabat C, Yanai H, et al. Dietary Therapy With the Crohn's Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy. J Crohns Colitis. 2017; 11(10): 1205–1212.
- Stein R, Daniel SG, Baldassano RN, et al. Outcomes and Predictors of Sustained Remission After Drug Withdrawal in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr. 2022; 75(5): 608–615.
- Sigall Boneh R, Westoby C, Oseran I, et al. The Crohn's Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions. Inflamm Bowel Dis. 2023 [Epub ahead of print].
- Fliss-Isakov N, Aviv Cohen N, Bromberg A, et al. Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease: Real-World Experience from a Tertiary Center. J Clin Med. 2023; 12(16).
- van Rheenen PF, Aloi M, Assa A, et al. The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. 2020 [Epub ahead of print].
- Bischoff SC, Escher J, Hébuterne X, et al. ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease. Clin Nutr. 2020; 39(3): 632–653.
- Bischoff SC, Bager P, Escher J, et al. ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clin Nutr. 2023; 42(3): 352–379.